Concepedia

Publication | Open Access

A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer

DOIFull Paper Access

54

Citations

37

References

2013

Year

Kimberly Kruczek, Megan Ratterman, Kathy Tolzien, Suela Sulo, Timothy M. Lestingi, Chadi Nabhan
British Journal of Cancer

Abstract

Temsirolimus monotherapy has minimal activity in chemotherapy-naïve CRPC.

References

YearCitations

Page 1